Hair vaccine: Myth or future therapeutic reality? Immunopharmacological perspectives on immune-regenerative strategies for hair loss.

Androgenetic alopecia (AGA) and alopecia areata (AA) are among the most prevalent hair loss disorders and continue to present significant therapeutic challenges, as currently available treatments primarily delay disease progression rather than achieve sustained hair follicle regeneration. Recent advances in immunopharmacology, regenerative medicine, and targeted drug-delivery technologies have renewed interest in the concept of a "hair vaccine." Unlike conventional prophylactic vaccines that elicit antigen-specific immune memory against infectious agents, hair follicles are immune-privileged self-tissues, making classical vaccination biologically unsuitable. This article evaluates the scientific rationale, pharmacological mechanisms, current evidence, and translational potential of vaccine-inspired immune-regenerative strategies for hair restoration. Relevant clinical, preclinical, and translational studies were identified through a comprehensive literature search focusing on hair follicle immune privilege, immune dysregulation, regenerative immunology, Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway inhibitors, biomimetic peptides, messenger RNA (mRNA)-based therapeutics, gene therapy, nanomedicine, exosomes, and biomaterial-assisted delivery systems. Available evidence indicates that targeted immune modulation can promote hair regrowth, particularly in AA, by suppressing pathogenic inflammation, restoring follicular immune homeostasis, and enhancing regenerative signaling. However, these approaches do not establish durable antigen-specific immune memory and therefore cannot be considered true vaccines. Major translational challenges include the absence of a defined follicular target antigen, disease heterogeneity, safety concerns related to immune modulation, and stringent regulatory requirements. Although no clinically validated hair vaccine currently exists, emerging immune-regenerative pharmacological strategies integrating localized immunomodulation, advanced biomaterials, gene-based therapies, and precision drug-delivery platforms offer promising avenues for achieving durable and targeted hair restoration.